Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Long-Term Investments (2020 - 2025)

Adma Biologics (ADMA) has disclosed Long-Term Investments for 6 consecutive years, with $8.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Investments rose 52.02% year-over-year to $8.6 million, compared with a TTM value of $8.6 million through Dec 2025, up 52.02%, and an annual FY2025 reading of $8.6 million, up 52.02% over the prior year.
  • Long-Term Investments was $8.6 million for Q4 2025 at Adma Biologics, down from $8.8 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $9.1 million in Q2 2025 and bottomed at $2.5 million in Q2 2021.
  • Average Long-Term Investments over 5 years is $5.5 million, with a median of $5.2 million recorded in 2024.
  • The sharpest move saw Long-Term Investments soared 93.04% in 2021, then dropped 16.98% in 2024.
  • Year by year, Long-Term Investments stood at $4.1 million in 2021, then rose by 17.27% to $4.8 million in 2022, then dropped by 2.1% to $4.7 million in 2023, then increased by 21.13% to $5.7 million in 2024, then skyrocketed by 52.02% to $8.6 million in 2025.
  • Business Quant data shows Long-Term Investments for ADMA at $8.6 million in Q4 2025, $8.8 million in Q3 2025, and $9.1 million in Q2 2025.